These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 15357010)
1. Optimizing the novel formulation of liposome-polycation-DNA complexes (LPD) by central composite design. Sun X; Zhang Z Arch Pharm Res; 2004 Jul; 27(7):797-805. PubMed ID: 15357010 [TBL] [Abstract][Full Text] [Related]
2. Optimizing the formulation of procationic liposomes-protamine-DNA complexes by response surface methodology. Zhong ZR; Liu ZB; Tu L; Zhang ZR; He Q PDA J Pharm Sci Technol; 2007; 61(4):324-32. PubMed ID: 17933213 [TBL] [Abstract][Full Text] [Related]
3. [Transfection efficiency comparison of cationic liposome-DNA complexes and lipid-protamine-DNA complexes in vitro]. Sun X; Tian L; Nie Y; Zhang Z; Lu J; Wei Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):191-5. PubMed ID: 17333920 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel diolein-based LPDII vector for gene delivery. Guo W; Gosselin MA; Lee RJ J Control Release; 2002 Sep; 83(1):121-32. PubMed ID: 12220844 [TBL] [Abstract][Full Text] [Related]
5. Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells. Sun X; Zhang HW; Zhang ZR World J Gastroenterol; 2004 Feb; 10(4):531-4. PubMed ID: 14966911 [TBL] [Abstract][Full Text] [Related]
6. [Preparation of lipid-protamine-DNA complexes and evaluation of their transfection efficiencies in vitro]. Sun X; Zhang ZR Yao Xue Xue Bao; 2004 Oct; 39(10):792-6. PubMed ID: 15700818 [TBL] [Abstract][Full Text] [Related]
7. Anionic LPD complexes for gene delivery to macrophage: preparation, characterization and transfection in vitro. Sun P; Zhong M; Shi X; Li Z J Drug Target; 2008 Nov; 16(9):668-78. PubMed ID: 18982515 [TBL] [Abstract][Full Text] [Related]
8. [Preparation and gene expression of transferrin modified gene loaded procationic liposomes]. Zhong ZR; Liu J; Deng Y; Zhang ZR; Song QG; He Q Yao Xue Xue Bao; 2007 Feb; 42(2):216-20. PubMed ID: 17518055 [TBL] [Abstract][Full Text] [Related]
9. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Li S; Rizzo MA; Bhattacharya S; Huang L Gene Ther; 1998 Jul; 5(7):930-7. PubMed ID: 9813664 [TBL] [Abstract][Full Text] [Related]
10. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Li S; Huang L Gene Ther; 1997 Sep; 4(9):891-900. PubMed ID: 9349425 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of a novel nonviral gene transfer system: procationic-liposome-protamine-DNA complexes. Zhong ZR; Liu J; Deng Y; Zhang ZR; Song QG; Wei YX; He Q Drug Deliv; 2007 Mar; 14(3):177-83. PubMed ID: 17454038 [TBL] [Abstract][Full Text] [Related]
12. Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes. Birchall JC; Kellaway IW; Gumbleton M Int J Pharm; 2000 Mar; 197(1-2):221-31. PubMed ID: 10704809 [TBL] [Abstract][Full Text] [Related]
13. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study. Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760 [TBL] [Abstract][Full Text] [Related]
14. Comparative study on preparative methods of DC-Chol/DOPE liposomes and formulation optimization by determining encapsulation efficiency. Yang S; Chen J; Zhao D; Han D; Chen X Int J Pharm; 2012 Sep; 434(1-2):155-60. PubMed ID: 22643228 [TBL] [Abstract][Full Text] [Related]
15. Optimization study on the formulation of roxithromycin dispersible tablet using experimental design. Weon KY; Lee KT; Seo SH Arch Pharm Res; 2000 Oct; 23(5):507-12. PubMed ID: 11059832 [TBL] [Abstract][Full Text] [Related]
16. Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes. Colonna C; Conti B; Genta I; Alpar OH Int J Pharm; 2008 Nov; 364(1):108-18. PubMed ID: 18775770 [TBL] [Abstract][Full Text] [Related]
17. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. Li B; Li S; Tan Y; Stolz DB; Watkins SC; Block LH; Huang L J Pharm Sci; 2000 Mar; 89(3):355-64. PubMed ID: 10707016 [TBL] [Abstract][Full Text] [Related]
18. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. Reddy JA; Low PS J Control Release; 2000 Feb; 64(1-3):27-37. PubMed ID: 10640643 [TBL] [Abstract][Full Text] [Related]
19. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression. Maitani Y; Igarashi S; Sato M; Hattori Y Int J Pharm; 2007 Sep; 342(1-2):33-9. PubMed ID: 17566677 [TBL] [Abstract][Full Text] [Related]
20. Dendritic cell targeted liposomes-protamine-DNA complexes mediated by synthetic mannosylated cholesterol as a potential carrier for DNA vaccine. Li P; Chen S; Jiang Y; Jiang J; Zhang Z; Sun X Nanotechnology; 2013 Jul; 24(29):295101. PubMed ID: 23799649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]